Nanoparticles Destroy Arterial Plaques

Video: Nanoparticles Destroy Arterial Plaques

Video: Nanoparticles Destroy Arterial Plaques
Video: Breakthrough: Nanoparticle Eats Plaque Responsible for Heart Attacks 2024, March
Nanoparticles Destroy Arterial Plaques
Nanoparticles Destroy Arterial Plaques
Anonim

Nanoparticles will clean the arteries of cholesterol plaques, according to AFP. The impact of the nanoparticles will be like that of miniature drones, the scientists explain.

At this stage, the method was tested only on rodents. More detailed research is needed to find out if this method can be used in humans.

Scientists strongly hope that this way of removing cholesterol plaques from the arteries may be the right way to fight atherosclerosis. This disease is among the leading causes of death in many countries around the world, added AFP.

One of the leaders of the study is Omid Farohzad, who works at the Harvard Medical Institute. For the first time, nanoparticles are used to limit atherosclerosis in animals, explains the specialist.

He also said that the team was able to use nanotechnology to treat infections and stabilize the number of plaques in atherosclerosis, and at an advanced stage. Research by scientists in this direction has lasted several years.

DNA
DNA

In this case, Harvard specialists used nanodrugs - the goal was to bring the treatment directly to the place where there are plaques. Some of the rodents that were treated had hardened arteries because they suffered from advanced atherosclerosis.

The scientists subjected the mice to the innovative therapy with nano-drugs - it lasted five weeks. Rodents that were in the control group did not undergo such treatment.

After five weeks, the rodents treated with the nanodrugs were in good health - the arteries were restored, the number of plaques stabilized, the researchers said.

Research and experiments with mice are certainly encouraging to experts, but they say that the technology must be studied in much more detail before it can be tested on humans. The entire study by Harvard experts is published in Science Translational Medicine.

Recommended: